Machine learning optimized multiparameter radar plots for B-cell acute lymphoblastic leukemia minimal residual
Kevin E Shopsowitz1, Lorraine Liu2, Audi Setiadi1,2
1Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
Optimized radar plots effectively distinguish B-lymphoblasts from normal B-cells in B-ALL MRD analysis, improving diagnostic accuracy. This method enhances minimal residual disease detection for better patient outcomes.
Area of Science:
- Hematology
- Immunology
- Computational Biology
Background:
- Flow cytometry is crucial for B-cell acute lymphoblastic leukemia (B-ALL) minimal residual disease (MRD) analysis.
- Distinguishing B-lymphoblasts from regenerative B-cells poses a challenge in MRD detection.
- Radar plots offer a potential solution by visualizing multiple markers simultaneously.
Purpose of the Study:
- To develop and optimize radar plots for accurate B-ALL MRD analysis.
- To improve the discrimination between malignant B-lymphoblasts and non-malignant B-cells.
Main Methods:
- Utilized Children's Oncology Group (COG) flow cytometry data from B-ALL cases.
- Employed an automated approach to generate and rank hundreds of radar plots using support vector machine (SVM) models.
- Compared optimized radar plots with principal component analysis (PCA), t-distributed stochastic neighbor embedding (t-SNE), and uniform manifold approximation and projection (UMAP) plots.
Main Results:
- Optimized radar plots significantly improved SVM area under the ROC curve (AUC) for B-ALL MRD detection.
- The performance of optimized radar plots was superior to PCA and comparable to UMAP, with enhanced generalizability.
- Radar plots accurately distinguished B-lymphoblasts from other CD19-positive populations and correlated strongly with serial gating for MRD quantification.
Conclusions:
- Optimized radar plots are effective tools for discriminating between B-lymphoblasts and non-malignant CD19-positive populations in B-ALL MRD analysis.
- The developed radar plot optimization strategy is adaptable to other MRD panels and clinical applications.
More Related Videos
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
07:35Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
Published on: October 11, 2018
